AliveCor Receives First FDA Clearance to Detect a Serious Heart Condition in an ECG on a Mobile Device Patients are able to instantly identify atrial fibrillation in real-time ECG recordings
SAN FRANCISCO, Aug. 21, 2014 /PRNewswire/ -- AliveCor, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted the company clearance for its algorithm to detect atrial fibrillation (AFib), the most common form of cardiac arrhythmia. AliveCor's automated analysis process (algorithm) instantly detects if patients are experiencing AFib through real-time electrocardiogram (ECG) recordings taken on the mobile phone based AliveCor® Heart Monitor, so physicians can intervene before potentially life-threatening conditions, like strokes, occur. Through AliveCor's ECG analysis service, patients can confirm their results with a U.S. board-certified cardiologist or a personal physician.
"The ability to automatically detect serious heart arrhythmia using mobile technology has the potential to save lives, reduce healthcare costs and allow patients and their caregivers to make informed decisions about cardiac care," said Euan Thomson, president and chief executive officer of AliveCor. "Having achieved clearance, we will work to incorporate the algorithm in our app and plan to make this available to customers during September."
One in four adults over age 40 develop AFib, making them five times more likely to have a stroke. AFib can be hard to detect, as symptoms, including heart palpitations, may be mild or non-existent. The AFib Detector represents a major step in the advancement of mobile phone based health, allowing patients to instantly know if AFib is present in their ECG. The company hopes to collect additional data and develop other algorithms over time.
"AliveCor is truly delivering on the promise of mobile health, placing medically relevant, intelligent tools in the hands of consumers worldwide," said Trudie Lobban MBE, Founder & CEO of AF Association & Arrhythmia Alliance. "We are excited about this milestone and look forward to using this technology to help those who suffer from arrhythmias identify when AFib is present in an effective and efficient way so they can work with their doctors to manage their condition."
The AliveCor Heart Monitor is intended to record, store and transfer electrocardiogram (ECG) rhythms. The AliveCor Heart Monitor also displays ECG rhythms and detects the presence of atrial fibrillation (when prescribed or used under the care of a physician). The AliveCor Heart Monitor is intended for use by healthcare professionals, patients with known or suspected heart conditions and health conscious individuals. The AliveCor Heart Monitor is compatible with all iPhone models and most Android mobile devices. Users will continue to have the ability to access their data confidentially anytime, anywhere.
For customers in the U.S., AliveCor Heart Monitor can be purchased at www.alivecor.com.
About AliveCor, Inc.
AliveCor, Inc., is a global innovator in mobile technology for heart health. AliveCor works with health systems to help identify patients with undiagnosed heart conditions before potentially life-threatening conditions, like stroke, can occur. AliveCor helps diagnosed patients work with their physician to monitor, track and manage their condition in new ways. AliveCor is a privately-held company headquartered in San Francisco, Calif. For more information, please visit www.alivecor.com.
+1 (415) 795-9807
SOURCE AliveCor, Inc.